About Halyard Health (NYSE:HYH)
Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment's products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E Ratio40.0756302521008
Forward P/E Ratio22.54
Sales & Book Value
Annual Sales$1.59 billion
Price / Sales1.38
Cash Flow$3.34 per share
Price / Cash14.04
Book Value$23.62 per share
Price / Book1.98
Net Income$39.80 million
Return on Equity8.65%
Return on Assets4.69%
Halyard Health (NYSE:HYH) Frequently Asked Questions
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
How were Halyard Health's earnings last quarter?
Halyard Health Inc (NYSE:HYH) released its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.47 by $0.13. The medical instruments supplier earned $401.40 million during the quarter, compared to analysts' expectations of $394.54 million. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The business's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.48 earnings per share. View Halyard Health's Earnings History.
When will Halyard Health make its next earnings announcement?
Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2018?
4 brokerages have issued 1-year target prices for Halyard Health's shares. Their predictions range from $42.00 to $52.00. On average, they anticipate Halyard Health's share price to reach $47.00 in the next twelve months. View Analyst Ratings for Halyard Health.
What are Wall Street analysts saying about Halyard Health stock?
Here are some recent quotes from research analysts about Halyard Health stock:
- 1. According to Zacks Investment Research, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. " (2/1/2018)
- 2. Stifel Nicolaus analysts commented, "HYH closed 2016 with its fourth consecutive quarter of sales and EPS upside relative to both Consensus and management guidance. After a more difficult than expected first-year (2015) post-spin, in 2016, the company's transformation took clearer shape and was highlighted by: accretive M&A, a positive mix shift to the more profitable Medical Device franchise (38% of sales; 64% of operating profit), successful re-negotiations of material GPO contracts, significant organic cost-savings and stepped-up investments, all with significantly improved cash flow generation ($100M+ guide vs. $160M actual). We continue to believe HYH has further price appreciation potential ahead as '2016-like' thematic drivers continue playing out over the next 12-24 months. Still, we acknowledge that HYH shares (+56% TTM vs. S&P500: +23%) trading at 20x 2018E EPS (vs. large cap ~18x) could "pause" here as the stock absorbs the recent out-performance and the next wave of potentially positive catalysts becomes more visible. Yet to be realized sales, margin, and EPS-enhancing catalysts could include: IT cost savings, better S&IP pricing, more normal nitrile pricing and most important, further accretive M&A opportunities. Company-specific 2017 headwinds could include: more intense commodity price inflation, stepped up On-Q competition, and still uncertain macro tax-related legislation. For us, the bottom line is that HYH remains a positive long-term transformation story that is still in 'early innings' with significant opportunity both organically and through acquisitions to leverage earnings. We rate HYH Buy and raise our TP to $45 (from $38)." (2/28/2017)
Who are some of Halyard Health's key competitors?
Some companies that are related to Halyard Health include VWR (VWR), LivaNova (LIVN), Integra Lifesciences (IART), Haemonetics (HAE), Neogen (NEOG), Inogen (INGN), NuVasive (NUVA), Nevro (NVRO), CONMED (CNMD), MiMedx Group (MDXG), Intersect ENT (XENT), OraSure Technologies (OSUR), Atrion (ATRI), Given Imaging (GIVN), Orthofix International (OFIX), K2M Group (KTWO), Cardiovascular Systems (CSII) and Invacare (IVC).
Who are Halyard Health's key executives?
Halyard Health's management team includes the folowing people:
- Ronald W. Dollens, Chairman of the Board (Age 70)
- Joseph F. Woody, Chief Executive Officer, Director (Age 51)
- Steven E. Voskuil, Chief Financial Officer, Senior Vice President (Age 48)
- Rhonda D. Gibby, Chief Human Resource Officer, Senior Vice President (Age 49)
- John W. Wesley, Senior Vice President, General Counsel (Age 59)
- Christopher G. Isenberg, Senior Vice President - Global Supply Chain and Procurement (Age 50)
- Warren J. Machan, Senior Vice President - Business Strategy (Age 51)
- Gary D. Blackford, Independent Director (Age 60)
- John P. Byrnes, Independent Director (Age 58)
- William A. Hawkins III, Independent Director (Age 62)
Who owns Halyard Health stock?
Halyard Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.55%), Goldman Sachs Group Inc. (3.65%), Paradice Investment Management LLC (3.24%), Bank of New York Mellon Corp (1.96%), Macquarie Group Ltd. (1.83%) and Copper Rock Capital Partners LLC (1.45%). View Institutional Ownership Trends for Halyard Health.
Who sold Halyard Health stock? Who is selling Halyard Health stock?
Halyard Health's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Gotham Asset Management LLC, Northpointe Capital LLC, Paradice Investment Management LLC, Metropolitan Life Insurance Co. NY, TIAA CREF Investment Management LLC and Guggenheim Capital LLC. View Insider Buying and Selling for Halyard Health.
Who bought Halyard Health stock? Who is buying Halyard Health stock?
Halyard Health's stock was purchased by a variety of institutional investors in the last quarter, including Channing Capital Management LLC, Macquarie Group Ltd., Deutsche Bank AG, Millennium Management LLC, Allianz Asset Management GmbH, Goldman Sachs Group Inc., MetLife Investment Advisors LLC and State of Wisconsin Investment Board. View Insider Buying and Selling for Halyard Health.
How do I buy Halyard Health stock?
Shares of Halyard Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Halyard Health's stock price today?
One share of Halyard Health stock can currently be purchased for approximately $46.88.
How big of a company is Halyard Health?
Halyard Health has a market capitalization of $2.24 billion and generates $1.59 billion in revenue each year. The medical instruments supplier earns $39.80 million in net income (profit) each year or $1.19 on an earnings per share basis. Halyard Health employs 12,000 workers across the globe.
How can I contact Halyard Health?
Halyard Health's mailing address is 5405 Windward Pkwy, ALPHARETTA, GA 30004-3894, United States. The medical instruments supplier can be reached via phone at +1-678-4259273 or via email at [email protected]
MarketBeat Community Rating for Halyard Health (HYH)MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Halyard Health (NYSE:HYH) Earnings History and Estimates Chart
Halyard Health (NYSE HYH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/1/2017||Q3 2017||$0.47||$0.60||$394.54 million||$401.40 million||View||N/A|
|8/2/2017||Q2 2017||$0.37||$0.51||$399.16 million||$399.20 million||View||Listen|
|5/2/2017||Q1 2017||$0.43||$0.48||$391.56 million||$395.60 million||View||Listen|
|2/27/2017||Q416||$0.44||$0.50||$401.72 million||$410.00 million||View||Listen|
|11/2/2016||Q316||$0.39||$0.48||$387.64 million||$398.00 million||View||N/A|
|8/3/2016||Q216||$0.36||$0.45||$383.08 million||$400.00 million||View||N/A|
|5/4/2016||Q116||$0.34||$0.53||$369.80 million||$385.00 million||View||N/A|
|2/29/2016||Q415||$0.50||$0.57||$401.96 million||$401.40 million||View||Listen|
|11/3/2015||Q315||$0.47||$0.52||$388.00 million||$390.00 million||View||N/A|
|8/4/2015||Q215||$0.53||$0.52||$401.70 million||$389.30 million||View||N/A|
|5/4/2015||Q1 2015||$0.64||$0.51||$390.00 million||$394.00 million||View||N/A|
|3/4/2015||Q4||$0.75||$1.59||$425.10 million||$439.40 million||View||N/A|
Halyard Health (NYSE:HYH) Earnings Estimates
Current Year EPS Consensus Estimate: $2.08 EPS
Next Year EPS Consensus Estimate: $2.14 EPS
Dividend History for Halyard Health (NYSE:HYH)
No dividend announcements for this company have been tracked by MarketBeat.com
Halyard Health (NYSE HYH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 90.05%
Halyard Health (NYSE HYH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/4/2015||Robert E Abernathy||CEO||Buy||10,000||$31.06||$310,600.00||80,043|| |
|9/1/2015||Steven E Voskuil||CFO||Buy||1,000||$30.00||$30,000.00||28,729|| |
Halyard Health (NYSE HYH) News Headlines
|Halyard Health (HYH) Scheduled to Post Quarterly Earnings on Monday|
www.americanbankingnews.com - February 19 at 4:30 AM
| Analysts Anticipate Halyard Health Inc (HYH) to Post $0.49 Earnings Per Share|
www.americanbankingnews.com - February 18 at 1:34 PM
|Halyard Health, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2017 Financial Results|
finance.yahoo.com - February 13 at 9:52 AM
|Halyard Health Inc (HYH) Given Average Rating of "Buy" by Brokerages|
www.americanbankingnews.com - February 3 at 9:36 PM
|Halyard Health Inc (HYH) Expected to Announce Quarterly Sales of $417.93 Million|
www.americanbankingnews.com - February 3 at 4:38 AM
|Halyard Health (HYH) Downgraded by Zacks Investment Research to Hold|
www.americanbankingnews.com - February 2 at 12:36 AM
| Brokerages Expect Halyard Health Inc (HYH) Will Announce Earnings of $0.49 Per Share|
www.americanbankingnews.com - January 15 at 3:08 PM
|Head-To-Head Analysis: Meridian Bioscience (VIVO) & Halyard Health (HYH)|
www.americanbankingnews.com - January 13 at 11:26 AM
|Halyard Health Inc (HYH) Given Consensus Rating of "Buy" by Brokerages|
www.americanbankingnews.com - January 9 at 11:44 PM
|Wired News – Owens & Minor Plans to Reorganize Business into Two Segments Post Acquisition of Halyard Health's S&IP Business|
finance.yahoo.com - January 8 at 8:26 AM
|Halyard Health (HYH) Upgraded to Buy at Zacks Investment Research|
www.americanbankingnews.com - January 7 at 6:40 PM
|Halyard Health, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference|
finance.yahoo.com - January 3 at 10:54 AM
|Halyard Health (HYH) Upgraded to "Buy" at ValuEngine|
www.americanbankingnews.com - January 1 at 10:28 PM
|Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : January 1, 2018|
finance.yahoo.com - January 1 at 11:07 AM
|Zacks: Analysts Anticipate Halyard Health Inc (HYH) Will Announce Quarterly Sales of $417.93 Million|
www.americanbankingnews.com - December 31 at 3:58 AM
|Halyard Health, Inc. (HYH)|
finance.yahoo.com - December 30 at 3:36 PM
|$0.50 Earnings Per Share Expected for Halyard Health Inc (HYH) This Quarter|
www.americanbankingnews.com - December 29 at 7:24 PM
|ETFs with exposure to Halyard Health, Inc. : December 21, 2017|
finance.yahoo.com - December 21 at 3:39 PM
|Halyard Health Earns Relative Strength Rating Upgrade; Hits Key Threshold|
finance.yahoo.com - December 20 at 11:30 AM
|Halyard Health Inc (HYH) Receives Average Recommendation of "Buy" from Analysts|
www.americanbankingnews.com - December 15 at 7:43 PM
|Halyard Health, Inc. (HYH) Expected to Announce Earnings of $0.50 Per Share|
www.americanbankingnews.com - December 12 at 3:28 PM
|Halyard Health (HYH) Rating Increased to Buy at Zacks Investment Research|
www.americanbankingnews.com - December 10 at 12:08 AM
|Comparing Halyard Health (HYH) & Its Competitors|
www.americanbankingnews.com - December 8 at 9:08 PM
|Halyard Health (HYH) Raised to "B" at TheStreet|
www.americanbankingnews.com - December 6 at 10:38 PM
|Financial Review: Halyard Health (HYH) versus Its Competitors|
www.americanbankingnews.com - December 3 at 1:24 AM
|Comparing Halyard Health (HYH) & The Competition|
www.americanbankingnews.com - December 2 at 9:38 AM
|ETFs with exposure to Halyard Health, Inc. : December 1, 2017|
finance.yahoo.com - December 1 at 4:46 PM
|$418.06 Million in Sales Expected for Halyard Health, Inc. (HYH) This Quarter|
www.americanbankingnews.com - November 26 at 2:52 AM
|Reviewing Halyard Health (HYH) & The Competition|
www.americanbankingnews.com - November 24 at 11:30 AM
|Halyard Health, Inc. (HYH) Receives Consensus Rating of "Buy" from Analysts|
www.americanbankingnews.com - November 20 at 7:52 PM
|Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : November 15, 2017|
finance.yahoo.com - November 17 at 6:13 PM
|Analyzing Halyard Health (HYH) and Orthofix International N.V. (OFIX)|
www.americanbankingnews.com - November 16 at 11:14 PM
|Halyard Health (HYH) & Its Peers Critical Analysis|
www.americanbankingnews.com - November 16 at 5:06 PM
|Halyard Health's (HYH) Management Presents at Stifel Nicolaus Health Care Conference - Seeking Alpha|
seekingalpha.com - November 15 at 1:10 AM
|ETFs with exposure to Halyard Health, Inc. : November 13, 2017|
finance.yahoo.com - November 13 at 7:41 PM
|Sand In My Shoes - Pepsi Is Pouring Dividends|
seekingalpha.com - November 11 at 10:26 AM
|Halyard Health, Inc. to Present at Stifel 2017 Healthcare Conference|
finance.yahoo.com - November 8 at 9:28 PM
|Halyard Health, Inc. :HYH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017|
finance.yahoo.com - November 8 at 9:28 PM
|Halyard Health, Inc. (HYH) Expected to Announce Quarterly Sales of $415.46 Million|
www.americanbankingnews.com - November 7 at 2:30 AM
|Equities Analysts Set Expectations for Halyard Health, Inc.'s FY2017 Earnings (HYH)|
www.americanbankingnews.com - November 6 at 4:56 AM
|Halyard Health Meets 80-Plus Relative Strength Rating Benchmark|
finance.yahoo.com - November 5 at 7:11 PM
|Investors Buy High Volume of Halyard Health Call Options (HYH)|
www.americanbankingnews.com - November 5 at 3:48 AM
|Halyard Health, Inc. (HYH) Upgraded to Buy at ValuEngine|
www.americanbankingnews.com - November 4 at 3:30 PM
|ETFs with exposure to Halyard Health, Inc. : November 3, 2017|
finance.yahoo.com - November 4 at 1:36 AM
|Halyard Health, Inc. – Value Analysis (NYSE:HYH) : November 3, 2017|
finance.yahoo.com - November 4 at 1:36 AM
|Halyard Health's (HYH) Buy Rating Reaffirmed at Stifel Nicolaus|
www.americanbankingnews.com - November 3 at 6:32 PM
|Halyard Health, Inc. breached its 50 day moving average in a Bullish Manner : HYH-US : November 2, 2017|
finance.yahoo.com - November 3 at 7:59 AM
|Owens & Minor, Inc. -- Moody's places Owens & Minor's ratings under review for downgrade|
finance.yahoo.com - November 3 at 7:59 AM
|Corporate News Blog - Owens & Minor to Acquire Halyard’s S&IP Business|
finance.yahoo.com - November 3 at 7:59 AM
|Bloomberg Markets: Dave Wilson’s Chart, Stock of the Day Nov. 1|
www.bloomberg.com - November 2 at 1:55 AM
Halyard Health (NYSE:HYH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Halyard Health (NYSE:HYH) Income Statement, Balance Sheet and Cash Flow Statement
Halyard Health (NYSE HYH) Stock Chart for Tuesday, February, 20, 2018